The Cochrane Collaboration (charity 1045921), 2026: Cochrane's audited 2025 accounts. Total income about GBP 11.1m; royalties from Wiley's Cochrane Library licences GBP 6.948m; trusts and grants GBP 1.815m, of which GBP 1.741m is a Wellcome Trust award for ESIC; the year closed with a deficit of GBP 818,000.
Cochrane's core income continues to be derived predominantly from publication royalties associated with its principal output, the Cochrane Library, published by John Wiley & Sons, Ltd. (Wiley).
PDF p. 18
The Cochrane Collaboration (charity 1045921), 2026: Cochrane's audited 2025 accounts. Total income about GBP 11.1m; royalties from Wiley's Cochrane Library licences GBP 6.948m; trusts and grants GBP 1.815m, of which GBP 1.741m is a Wellcome Trust award for ESIC; the year closed with a deficit of GBP 818,000. Funder of the organisation (not of a review): publishing royalties from Wiley, plus trusts and grants (Wellcome Trust ESIC award) and national library licences. No pharmaceutical or device income is reported. The PDF prints no page numbers; 'PDF p. 18' is the 18th page of the file. File downloaded and text-extracted 2026-11-18. Study type: regulatory record.
